Market by Type, Form, Livestock, Application, End-user, and Country | Forecast 2021-2028
Triton’s
research report has ascertained that the North American eubiotics market is
predicted to develop at a compound annual growth rate of 7.15% through the
calculated years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries discussed in this market are:
• United States
• Canada
Chicken
consumption has surpassed beef over the past years across the region. Moreover,
pork is estimated to emerge as a popular meat product in the US in the next few
years. Furthermore, Americans are likely to consume a higher amount of broiler
chickens by 2030, as per the USDA and Economic Research Service estimate. Other
than this, the growing concerns relating to meat quality and its influence on
health have enhanced the demand for eubiotics across the region. Above all, the
surge in concerns pertaining to zoonotic diseases among animals is majorly
driving the development of the eubiotics market across the region.
Likewise,
the chicken consumption rate has increased over the years within Canada. As a
result, the production of chicken meat reached an all-time high in 2019.
Additionally, animal agriculture is crucial for the country’s prosperity.
Hence, the Canadian Pork Council and the meat, dairy, and poultry industries
are striving to protect farms and the livelihoods of producers from the threat
of multi-species infectious diseases. Therefore, the rise in meat consumption,
along with rising concerns relating to food safety, zoonotic diseases,
antimicrobial stewardship, and animal health, is likely to motivate the
progression of the Canadian eubiotics market over the near future.
Lallemand
Inc develops, produces, and distributes high-value year and bacteria products,
including yeast derivatives. These solutions positively impact animal
nutrition, forage management, and the animal environment. It caters to animal
nutrition, baking, fermented beverages, health, and pharmaceutical sectors.
Lallemand has operations across various regions, with headquarters located in
Ontario, Canada.
1. NORTH
AMERICA EUBIOTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON EUBIOTICS MARKET
2.2. KEY
INSIGHTS
2.2.1. EUBIOTICS
AS AN ALTERNATIVE TO ANTIBIOTICS
2.2.2. APPLICATIONS
OF EUBIOTICS IN CALVES' GUT HEALTH
2.2.3. DEVELOPING
FOOD ADDITIVE PLATFORM BASED ON GRAINS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. PRODUCT
LAUNCHES
2.6.4. EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISING
MEAT CONSUMPTION
2.7.2. GROWING
AWARENESS AND CONCERNS REGARDING ANIMAL HEALTH
2.7.3. INCREASING
DEMAND FOR MANUFACTURED FEEDS
2.8. MARKET
CHALLENGES
2.8.1. UNAWARENESS
ABOUT EUBIOTICS
2.9. MARKET
OPPORTUNITIES
2.9.1. GOVERNMENT
SUPPORT FOR EUBIOTICS USE
2.9.2. PROBIOTICS
SPRAY COATINGS
2.9.3. ESSENTIAL
OILS FOR NECROTIC ENTERITIS
3. NORTH
AMERICA EUBIOTICS MARKET OUTLOOK - BY TYPE
3.1. PROBIOTICS
3.2. ORGANIC
ACID
3.3. PREBIOTICS
3.4. ESSENTIAL
OILS
4. NORTH
AMERICA EUBIOTICS MARKET OUTLOOK - BY FORM
4.1. DRY
4.2. LIQUID
5. NORTH
AMERICA EUBIOTICS MARKET OUTLOOK - BY LIVESTOCK
5.1. SWINE
5.2. POULTRY
5.3. RUMINANTS
5.4. AQUACULTURE
5.5. OTHER
LIVESTOCK
6. NORTH
AMERICA EUBIOTICS MARKET OUTLOOK - BY APPLICATION
6.1. GUT
HEALTH
6.2. IMMUNITY
6.3. YIELD
MANAGEMENT
6.4. OTHER
APPLICATIONS
7. NORTH
AMERICA EUBIOTICS INDUSTRY OUTLOOK - BY END-USER
7.1. ANIMALS
7.2. HUMANS
8. NORTH
AMERICA EUBIOTICS MARKET – REGIONAL OUTLOOK
8.1. UNITED
STATES
8.2. CANADA
9. COMPETITIVE
LANDSCAPE
9.1. ANPARIO
PLC
9.2. ARCHER
DANIELS MIDLAND
9.3. BASF
SE
9.4. BEHN
MEYER GROUP
9.5. BENEO
GMBH
9.6. CARGILL
INC
9.7. CHR
HANSEN HOLDING AS
9.8. DUPONT
DE NEMOURS INC
9.9. KEMIN
INDUSTRIES INC
9.10. KONINKLIJKE
DSM NV
9.11. LALLEMAND
INC
9.12. LESAFFRE
9.13. NEOSPARK
DRUGS AND CHEMICALS PRIVATE LIMITED
9.14. NOVUS
INTERNATIONAL INC
9.15. YARA
INTERNATIONAL ASA
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: COUNTRIES WITH
THE HIGHEST ANNUAL MEAT CONSUMPTION
TABLE 4: MAJOR LIVESTOCK
DISEASES IN THE WORLD
TABLE 5: NORTH AMERICA
EUBIOTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA
EUBIOTICS MARKET, BY FORM, 2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
EUBIOTICS MARKET, BY LIVESTOCK, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
EUBIOTICS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
EUBIOTICS MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
EUBIOTICS MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET ATTRACTIVENESS INDEX
FIGURE 2: NORTH AMERICA EUBIOTICS MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE 3: NORTH AMERICA EUBIOTICS MARKET, BY PROBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 4: NORTH AMERICA EUBIOTICS MARKET, BY ORGANIC ACID, 2021-2028 (IN
$ MILLION)
FIGURE 5: NORTH AMERICA EUBIOTICS MARKET, BY PREBIOTICS, 2021-2028 (IN $
MILLION)
FIGURE 6: NORTH AMERICA EUBIOTICS MARKET, BY ESSENTIAL OILS, 2021-2028
(IN $ MILLION)
FIGURE 7: NORTH AMERICA EUBIOTICS MARKET, BY FORM, 2020 & 2028 (IN %)
FIGURE 8: NORTH AMERICA EUBIOTICS MARKET, BY DRY, 2021-2028 (IN $
MILLION)
FIGURE 9: NORTH AMERICA EUBIOTICS MARKET, BY LIQUID, 2021-2028 (IN $
MILLION)
FIGURE 10: NORTH AMERICA EUBIOTICS MARKET, BY LIVESTOCK, 2020 & 2028
(IN %)
FIGURE 11: NORTH AMERICA EUBIOTICS MARKET, BY SWINE, 2021-2028 (IN $
MILLION)
FIGURE 12: NORTH AMERICA EUBIOTICS MARKET, BY POULTRY, 2021-2028 (IN $
MILLION)
FIGURE 13: NORTH AMERICA EUBIOTICS MARKET, BY RUMINANTS, 2021-2028 (IN $
MILLION)
FIGURE 14: NORTH AMERICA EUBIOTICS MARKET, BY AQUACULTURE, 2021-2028 (IN
$ MILLION)
FIGURE 15: NORTH AMERICA EUBIOTICS MARKET, BY OTHER LIVESTOCK, 2021-2028
(IN $ MILLION)
FIGURE 16: NORTH AMERICA EUBIOTICS MARKET, BY APPLICATION, 2020 &
2028 (IN %)
FIGURE 17: NORTH AMERICA EUBIOTICS MARKET, BY GUT HEALTH, 2021-2028 (IN $
MILLION)
FIGURE 18: NORTH AMERICA EUBIOTICS MARKET, BY IMMUNITY, 2021-2028 (IN $
MILLION)
FIGURE 19: NORTH AMERICA EUBIOTICS MARKET, BY YIELD MANAGEMENT, 2021-2028
(IN $ MILLION)
FIGURE 20: NORTH AMERICA EUBIOTICS MARKET, BY OTHER APPLICATIONS,
2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA EUBIOTICS MARKET, BY END-USER, 2020 & 2028
(IN %)
FIGURE 22: NORTH AMERICA EUBIOTICS MARKET, BY ANIMALS, 2021-2028 (IN $
MILLION)
FIGURE 23: NORTH AMERICA EUBIOTICS MARKET, BY HUMANS, 2021-2028 (IN $
MILLION)
FIGURE 24: NORTH AMERICA EUBIOTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028
(IN %)
FIGURE 25: UNITED STATES EUBIOTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: CANADA EUBIOTICS MARKET 2021-2028 (IN $ MILLION)